EDITOR,-I read with great interest the article by Hearing et al (Gut 1999; 45:889-894) on the eVect of cholecystectomy on bowel function. In this elegant publication, however, the authors mistakenly assume that published estimates of the prevalence of postcholecystectomy diarrhoea derive from retrospective or uncontrolled data only. In this context I would like to draw attention to earlier publications derived from the Rotterdam Gallstone Study. 1 2 In the first paper the results are discussed of a prospective analysis of biliary and gastrointestinal symptoms (including diarrhoea) prior to and up to two years after gall stone therapy. 1 Therapy consisted of either conventional cholecystectomy or extracorporeal shock wave lithotripsy (ESWL), allocated randomly. The second paper focused on surgery and reported on symptoms before and after conventional and laparoscopic cholecystectomy. 2 This study was based on the same concept, and treatment depended on the availability of a laparoscopic set. Generally, we found that the reported incidence of diarrhoea before and after surgery did not change. In fact, there was no diVerence in the reported incidence of diarrhoea at any time between cholecystectomy and gall bladder preserving therapy (that is, ESWL). We also found that there were no diVerences in the reported incidence or severity of diarrhoea between laparoscopic and conventional cholecystectomy at any time.
Although the study design of our two studies diVered largely from that of Hearing's, the results and conclusions are in agreement, in that clinical diarrhoea seldom develops after cholecystectomy. O'Donnell is correct that objective assessment rarely demonstrates new onset diarrhoea after cholecystectomy. 3 I agree with Hearing et al that postcholecystectomy diarrhoea is in fact an unproved entity. Given our and Hearing's results, I doubt if more prospective studies are needed to solve this problem. 
MALT lymphomas and Helicobacter pylori?
EDITOR,-Raderer et al (Gut 2000; 46:133-5) present an interesting case report of a patient with a mucosa associated lymphoid tissue (MALT) lymphoma of the stomach and descending colon. Their report adds to the growing literature of gastrointestinal MALT lymphomas that respond to antibiotic treatment. In addition to the numerous reports on antibiotic sensitive gastric lymphomas, 1 those of the small intestine, 2 salivary glands, 3 4 nasal mucosa, 5 and colon 6 7 have recently been reported. Although Helicobacter pylori is generally implicated as the inducing agent, this does not always appear to be the case. A related bacterium, H heilmannii, has also been found in association with gastric MALT lymphomas, including H pylori negative patients whose disease was still responsive to antibiotic treatment. 8 Furthermore, other non-H pylori bacterial 9 and protozoal 10 flora have been observed in gastric lymphomas specific to involved regions. In the report by Raderer et al, and in several of the others previously mentioned, 3-7 H pylori was not identified in the extragastric lesions, leaving it open to speculation how H pylori may induce antigenic stimulation of these lymphomas. Moreover, in the report by Inoue and Chiba, 7 not only was the rectal lesion H pylori negative but upper gastrointestinal endoscopy was normal. Their patient was seronegative for H pylori and had a negative rapid urease test, culture, and histological examination.
In light of this evidence, it seems that although H pylori may be the most common cause of many gastrointestinal MALT lymphomas, it is not the only causative organism. This is an important point to consider when confronted with patients diagnosed with H pylori negative MALT lymphomas. In my own study, comprising 201 subjects with iron deficiency (characterised by serum ferritin <18 µg/l), the MCH conferring optimum trade oV between sensitivity (65.2%) and specificity (65.9%) for iron deficiency was <24 pg, and this yielded a positive predictive value of 70%. By contrast, for MCV, optimum trade oV between sensitivity (61.7%) and specificity (59.1%) was obtained with a cut oV level of <77 fl, giving a positive predictive value of 65%. 3 There were 31 patients with an MCH <26 pg in the presence of an MCV >80 fl compared with only four with an MCV <80 fl in the presence of an MCH >26 pg 3 and, among these, four had an MCH <24 pg in the presence of an MCV >77 fl in contrast with only one with an MCV <77 fl in the presence of an MCH >24 pg. In my study, the most stringent cut oV diagnostic level for iron deficiency was a serum ferritin level <10 µg/l found in a subgroup of 145 subjects. At this level, the MCV characterised by optimum trade oV between sensitivity (65%) and specificity (66%) was <76 fl (identical with the cut oV level in the guidelines), and this yielded a positive predictive value of 55%. Correspondingly, the optimum MCH was either <24 pg, characterised by sensitivities, specificities, and positive predictive values of 74%, 59%, and 80%, respectively, or <23 pg, characterised by sensitivities, specificities, and positive predictive values of 58%, 75%, and 62%, respectively. Reply EDITOR,-Suggesting both that transferrin saturation may help in the diagnosis and that ferritin is the most powerful test for iron deficiency anaemia (IDA) is not contradictory.
Being the most powerful test does not mean it is always reliable. For example, in inflammatory conditions such as rheumatoid arthritis, ferritin may be normal even if there is iron deficiency. We find the reference to the greater reliability of mean corpuscular haemoglobin (MCH) compared with mean corpuscular volume (MCV) in diagnosing IDA interesting. We agree that MCH can be useful in the diagnosis of iron deficiency. However, none of the papers quoted takes account of the red cell distribution width (RDW). We wonder if Dr Jolobe would still be able to demonstrate the superiority of MCH compared with MCV if anaemic patients with a normal MCV but raised RDW were excluded. We explain in our guidelines that combined deficiency (that is, iron deficiency together with B12 and/or folate deficiency) may be associated with a normal MCV and may be recognised by a raised RDW. 
